Sells surgical equipment and systems, patient-care and emergency products, vascular and brain-surgery devices, and joint-replacement and trauma implants to doctors, hospitals and other healthcare facilities.
10-K for FY2025, filed Feb 11, 2026Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent…View ↗
MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies, and navigation systems…View ↗
Orthopaedics. MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and…View ↗
Customers buy MedSurg and Neurotechnology products mainly at shipment or receipt; Orthopaedics sales follow a purchase order and notice that the product was used or implanted.
8-K, filed Jun 26, 2026 10-K for FY2025, filed Feb 11, 2026
$25.1B
10-K for FY2025, filed Feb 11, 2026
$25.1B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
MedSurg and Neurotechnology
Sold outright
10-K for FY2025, filed Feb 11, 2026 |
55%
FY2022: 59%
|
MedSurg and Neurotechnology, FY2025
$13.7B Sources
|
Sold outright |
|
Orthopaedics
Sold outright
10-K for FY2025, filed Feb 11, 2026 |
45%
FY2022: 41%
|
Orthopaedics, FY2025
$11.4B Sources
|
Sold outright |
Products are sold through company-owned subsidiaries and branches and third-party dealers and distributors; most are marketed directly to doctors, hospitals and other healthcare facilities.
10-K for FY2025, filed Feb 11, 2026Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent…View ↗
Yes. It kept 13 cents of every revenue dollar as net income in FY2025 and turned 17 cents into free cash flow.
10-Q for Q3 FY2026, filed Oct 30, 2026
Open tableView ↗
8-K, filed Oct 29, 2026
We are updating our full year 2026 guidance and now expect organic net sales growth(2) in the range of 6.5% to 7.0% and adjusted net…View ↗
8-K, filed Oct 6, 2026
Stryker Corporation (the “Company”) announced on October 6, 2026 that Kevin A. Lobo will resign from his role as Chief Executive Officer…View ↗
Growing. Revenue grew 47% in 4 years, from $17.1B in FY2021 to $25.1B in FY2025, about 10% a year.
Broader stroke and vascular treatments
The earlier report describes minimally invasive products for acute ischemic stroke under Neurovascular; the latest also lists hemorrhagic stroke and venous thromboembolism treatments under Vascular.
10-K for FY2022, filed Feb 10, 2023 10-K for FY2025, filed Feb 11, 2026MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic…View ↗
MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies, and navigation systems…View ↗
Virtual care technology
Medical's earlier description mentions clinical communication and workflow solutions; the latest adds an AI-assisted virtual care platform to its clinical communication products.
10-K for FY2022, filed Feb 10, 2023 10-K for FY2025, filed Feb 11, 2026MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic…View ↗
MedSurg and Neurotechnology products include surgical equipment, patient and caregiver safety technologies, and navigation systems…View ↗
Competes with Zimmer, Medtronic, Johnson & Johnson MedTech, CONMED, Karl, Olympus Optical, Smith & Nephew, Arthrex, STERIS, Baxter International, Zoll, Medline Industries, Ferno-Washington, Terumo, and Penumbra
10-K for FY2025, filed Feb 11, 2026We are one of five leading global competitors in Instruments; the other four being Zimmer Biomet Holdings, Inc. (Zimmer),View ↗
Loading...